BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6592614)

  • 1. In vivo assessment of urinary bladder malignancy.
    Karr JP; Pontes JE; Murphy GP; Gibas Z; Sandberg AA
    Prog Clin Biol Res; 1984; 162A():331-46. PubMed ID: 6592614
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
    Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal characterization and isoenzyme pattern of non-malignant and malignant human urothelial cell lines.
    Debiec-Rychter M; Christensen B; Kieler J; Wang CY
    Anticancer Res; 1986; 6(5):1237-44. PubMed ID: 3800330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Low-grade and low-stage transitional carcinoma of the bladder. Review].
    Escudero Barrilero A; Gutiérrez Sanz Gadea C; Hernández Fernández C; Romero Maroto J; Tallada Buñuel M; Perales Cabanas L
    Actas Urol Esp; 1985; 9(3):203-8. PubMed ID: 3898736
    [No Abstract]   [Full Text] [Related]  

  • 5. The prognostic meaning of marker chromosomes in human urinary bladder carcinoma.
    Burk K; Harbott J
    Prog Clin Biol Res; 1984; 162A():347-57. PubMed ID: 6592615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an agar-methyl cellulose clonogenic assay for cells in transitional cell carcinoma of the human bladder.
    Buick RN; Stanisic TH; Fry SE; Salmon SE; Trent JM; Krasovich P
    Cancer Res; 1979 Dec; 39(12):5051-6. PubMed ID: 498131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment by M-FISH of karyotypic complexity and cytogenetic evolution in bladder cancer in vitro.
    Ratliff TL
    J Urol; 2005 Nov; 174(5):2065. PubMed ID: 16217396
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel recurrent structural chromosomal aberrations in primary bladder cancer.
    Panani AD; Ferti AD; Raptis SA; Roussos C
    Anticancer Res; 2004; 24(5A):2967-74. PubMed ID: 15517903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular cytogenetic study of bladder transitional cell carcinoma by FISH].
    Shou J; Wang M; Ma J
    Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):36-8. PubMed ID: 11776593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistomorphologic and molecular cytogenetic analysis of a carcinosarcoma of the urinary bladder.
    Gronau S; Menz CK; Melzner I; Hautmann R; Möller P; Barth TF
    Virchows Arch; 2002 Apr; 440(4):436-40. PubMed ID: 11956826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chromosomal analysis of primary superficial tumors of the bladder].
    Martorana G; Giberti C; de Ferrari M; Ottaggio L; Giuliani L
    J Urol (Paris); 1983; 89(7):489-92. PubMed ID: 6655279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current topics in the pathology of bladder cancer.
    Murphy WM
    Pathol Annu; 1983; 18 Pt 1():1-25. PubMed ID: 6410347
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of genetic alterations in normal bladder urothelium.
    Leonardo C; Gallucci M; Cianciulli AM
    Urology; 2004 Aug; 64(2):405; author reply 405-6. PubMed ID: 15302516
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on growth of human bladder tumors. The relationship between the proliferative cell population, the chromosome pattern and histology.
    Neagu V; Lazar C; Mares V; Pop T; Ioanid PC
    Neoplasma; 1979; 26(2):195-200. PubMed ID: 471126
    [No Abstract]   [Full Text] [Related]  

  • 15. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
    Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
    Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors and markers used in urothelial carcinoma of the bladder].
    Billerey C; Vieillefond A
    Ann Pathol; 1999; 19(5 Suppl):S107-9. PubMed ID: 10599469
    [No Abstract]   [Full Text] [Related]  

  • 17. Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia.
    Chaturvedi V; Li L; Hodges S; Johnston D; Ro JY; Logothetis C; von Eschenbach AC; Batsakis JG; Czerniak B
    Oncogene; 1997 May; 14(17):2059-70. PubMed ID: 9160886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer.
    Montie JE
    J Urol; 2005 Sep; 174(3):869-70. PubMed ID: 16093975
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytogenetic analysis of 62 transitional cell bladder carcinomas.
    Granberg-Ohman I; Tribukait B; Wijkström H
    Cancer Genet Cytogenet; 1984 Jan; 11(1):69-85. PubMed ID: 6690024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome markers and progression in bladder cancer.
    Sandberg AA
    Cancer Res; 1977 Aug; 37(8 Pt 2):2950-6. PubMed ID: 872125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.